Hepatitis B–Induced IL8 Promotes Hepatocellular Carcinoma Venous Metastasis and Intrahepatic Treg Accumulation
Open accessPublished version of a preprint
The DOI matches its Crossref record; 56 of the 59 references it cites were found in a registry or an index.
Abstract
Hepatitis B–associated hepatocellular carcinoma (HCC) is often accompanied by severe vascular invasion and portal vein tumor thrombus, leading to a poor prognosis. However, the underlying mechanism of this disease remains obscure. In this study, we demonstrate that the hepatitis B virus (HBV)–encoded gene HBx induces high IL8 production through MEK–ERK signal activation, leading to enhanced endothelial permeability to facilitate tumor vascular invasion. In a vascular metastatic model using a tail vein injection in a transgenic mouse with selective expression of human CXCR1 in the endothelium, activation of the IL8–CXCR1 cascade by overexpression of IL8 in tumor cells dramatically enhanced liver metastasis. Mechanistically, IL8 selectively induced GARP-latent-TGFβ in liver sinusoidal endothelial cells and subsequently provoked preferential regulatory T-cell polarization to suppress antitumor immunity. Collectively, these findings reveal a hepatitis B–associated IL8–CXCR1 signaling axis that mediates vascular invasion and local microenvironmental immune escape of HCC to induce intrahepatic metastasis, which may serve as potential therapeutic targets for HBV-associated HCC. Significance: This study identifies a hepatitis B–induced IL8/CXCR1/TGFβ signaling cascade that suppresses antitumor immunity and enhances metastasis in hepatocellular carcinoma, providing new potential targets for therapeutic intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The IL-8/CXCR1 axis also induces glycoprotein-A repetitions predominant (GARP)-latent-TGFβ in liver sinusoidal endothelial cells to subsequently provoke preferential regulatory T-cell polarization to suppress antitumor immunity [328].”
From Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells (2025) · doi:10.1038/s41423-025-01313-7 · cites this paper as [328]
In the citing paper
“Additionally, LSECs participate in vascular invasion and local microenvironmental immune escape in HCC [328].”
From Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells (2025) · doi:10.1038/s41423-025-01313-7 · cites this paper as [328]
In the citing paper
“In this context, HBV-associated tumor cells release high amounts of interleukin 8 (IL-8), which binds to endothelial CXCR1, leading to increased LSEC permeability to facilitate tumor invasion.”
From Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells (2025) · doi:10.1038/s41423-025-01313-7 · cites this paper as [328]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Cancer statistics in China, 2015
Chen, W., Zheng, R., Baade, P. D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X. Q., & He, J. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21338 · Cited by 17,038
Siegel, R. L., Miller, K. D., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21442 · Cited by 16,579
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Tang, Z., Li, C., Kang, B., Gao, G., Li, C., & Zhang, Z. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx247 · Cited by 9,849
Self-citationForner, A., Reig, M., & Bruix, J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30010-2 · Cited by 5,531
AASLD guidelines for the treatment of hepatocellular carcinoma
Heimbach, J. K., Kulik, L. M., Finn, R. S., Sirlin, C. B., Abecassis, M. M., Roberts, L. R., Zhu, A. X., Murad, M. H., & Marrero, J. A. (2018) · Hepatology · doi:10.1002/hep.29086 · Cited by 4,070
ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform
Rhodes, D. R., Yu, J., Shanker, K., Deshpande, N., Varambally, R., Ghosh, D., Barrette, T., Pander, A., & Chinnaiyan, A. M. (2004) · Neoplasia · doi:10.1016/s1476-5586(04)80047-2 · Cited by 3,612
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
Nagarsheth, N., Wicha, M. S., & Zou, W. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.49 · Cited by 2,206
Yan, H., Zhong, G., Xu, G., He, W., Jing, Z., Gao, Z., Huang, Y., Qi, Y., Peng, B., Wang, H., et al. (2012) · eLife · doi:10.7554/elife.00049 · Cited by 2,115
Self-citationEvidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
Bruix, J., Reig, M., & Sherman, M. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.12.041 · Cited by 1,694
Cited by
Xin, X., Cheng, X., Zeng, F., Xu, Q., & Hou, L. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.89568 · Cited by 120
(2025) · doi:10.1038/s41423-025-01313-7 · Cited by 97
Cytokines and Chemokines in HBV Infection
Zhong, S., Zhang, T., Tang, L., & Li, Y. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.805625 · Cited by 99
The role of IL-8 in cancer development and its impact on immunotherapy resistance
Meier, C., & Brieger, A. (2025) · European Journal of Cancer · doi:10.1016/j.ejca.2025.115267 · Cited by 82
Wang, X., Liu, C., Chen, J., Chen, L., Ren, X., Hou, M., Cui, X., Jiang, Y., Liu, E., Zong, Y., et al. (2022) · Cell Discovery · doi:10.1038/s41421-022-00445-8 · Cited by 79
Self-citation
Metadata
- Authors
- Zhang, C., Gao, Y., Du, C., Markowitz, G. J., Fu, J., Zhang, Z., Liu, C., Qin, W., Wang, H., Wang, F., & Yang, P.
- Affiliations
- University of Science and Technology of China (CN)
- Chinese Academy of Sciences (CN)
- Weill Cornell Medicine (US)
- Second Military Medical University (CN)
- Corresponding author
- Wang, Fan
- Yang, Pengyuan
- ORCID
- Venue
- Cancer Research
- Published
- 2021-03-02
- Volume
- 81
- Issue
- 9
- Pages
- 2386-2398
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W3135090205
- Cited by
- 72
- References
- 59
- Citations by year
- 2026: 4 · 2025: 14 · 2024: 17 · 2023: 20 · 2022: 14 · 2021: 3
- FWCI
- 4.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Cancer Research (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Strategic Priority Research Program (XDB29040102, XDB37030206)
- National Natural Science Foundation of China (81672464, 81988101, 81872231, 82073411)
- NCI (KL2-TR-002385)
- Topics
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- interleukin-8, CXCR1, HBx, MEK/ERK signaling, liver metastasis, intrahepatic metastasis, regulatory T cells, TGF-beta, liver sinusoidal endothelial cells, endothelial permeability, tumor vascular invasion, immune evasion
- MeSH terms
- Animals, Disease Models, Animal, Hepatitis B, Hepatitis B virus, Carcinoma, Hepatocellular, Humans, Liver, Liver Neoplasms, Mice, Inbred C57BL, Mice, Transgenic, Recombinant Proteins, Transfection, Trans-Activators, Interleukin-8, MAP Kinase Signaling System, Receptors, Interleukin-8A, T-Lymphocytes, Regulatory, Mice, Viral Regulatory and Accessory Proteins, Hep G2 Cells, HEK293 Cells, Human Umbilical Vein Endothelial Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hepatitis B–Induced IL8 Promotes Hepatocellular Carcinoma Venous Metastasis and Intrahepatic Treg Accumulation. https://app.cochat.ai/papers/10.1158/0008-5472.can-20-3453
- The paper
- Zhang, C., Gao, Y., Du, C., Markowitz, G. J., Fu, J., Zhang, Z., Liu, C., Qin, W., Wang, H., Wang, F., & Yang, P. (2021). Hepatitis B–Induced IL8 Promotes Hepatocellular Carcinoma Venous Metastasis and Intrahepatic Treg Accumulation. Cancer Research. https://doi.org/10.1158/0008-5472.can-20-3453
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.







